On the recordSeptember 16, 2015
It will be important that healthcare providers and patients have that same confidence in the safety and efficacy of FDA-approved biosimilars.
Source
congress.govIt will be important that healthcare providers and patients have that same confidence in the safety and efficacy of FDA-approved biosimilars.
Emphasizing the need for confidence in biosimilars similar to generics.
Share
More from Susan Collins
I vote very independently. ... I am the most bipartisan member of the Senate.
The bottom line is, I support him when I think he's right. I don't when I think he's wrong.
He'll be 100 in seniority, and all of that essential federal funding targeted for the state of Maine, virtually all of it will go away.